Formula Systems (1985) Ltd: Form 20-F for the period ended Dec 31, 2013
Filed with the SEC on Apr 30, 2014 and accepted by EDGAR at Apr 30, 2014, 12:31 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2013-01-01 to 2013-12-31 | $796.7m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2013-01-01 to 2013-12-31 | $603.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2013-01-01 to 2013-12-31 | $193.6m | us-gaap:GrossProfit |
| Research and development | 12 months2013-01-01 to 2013-12-31 | $14.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2013-01-01 to 2013-12-31 | $117.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2013-01-01 to 2013-12-31 | $61.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2013-01-01 to 2013-12-31 | $6.2m | us-gaap:InterestExpense |
| Income tax | 12 months2013-01-01 to 2013-12-31 | $8.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2013-01-01 to 2013-12-31 | $81.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2013-01-01 to 2013-12-31 | $5.70 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2013-01-01 to 2013-12-31 | $5.90 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2013-01-01 to 2013-12-31 | 14,122,779 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2013-01-01 to 2013-12-31 | $68.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2013-01-01 to 2013-12-31 | $6.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2013-12-31 | $82.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-12-31 | $338.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-12-31 | $877.5m | us-gaap:Assets |
| Current liabilities | At period end2013-12-31 | $211.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-12-31 | $395.6m | us-gaap:Liabilities |
| Long-term debt | At period end2013-12-31 | $0 | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2013-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2013-12-31 | $322.2m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2013-12-31 | 14,718,782 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001144204-14-026077. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.